1. Treatment of postmenopausal osteoporosis;Eastell R;N Engl J Med,1998
2. Socio-Economic Status and Prevalence of Self-Reported Osteoporosis in Tehran: Results from a Large Population-Based Cross-Sectional Study (Urban HEART-2). Journal of urban health: bulletin of the New York Academy of Medicine;Asadi-Lari M
3. Economic Consequences and Potentially Preventable Costs Related to Osteoporosis in the Netherlands. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research;Dunnewind T
4. Fahimfar N, Noorali S, Yousefi S, Gharibzadeh S, Shafiee G, Panahi N et al. Prevalence of osteoporosis among the elderly population of Iran. Archives of osteoporosis. 2021 Jan 21;16(1):16. PubMed PMID: 33475880. Epub 2021/01/22. eng.
5. Borgström F, Karlsson L, Ortsäter G, Norton N, Halbout P, Cooper C et al. Fragility fractures in Europe: burden, management and opportunities. Archives of osteoporosis. 2020 Apr 19;15(1):59. PubMed PMID: 32306163. Pubmed Central PMCID: PMC7166207. Epub 2020/04/20. eng.